CSV and data integrity
GAMP 5 lifecycle strategy, 21 CFR Part 11, Annex 11, URS, risk assessment, IQ/OQ/PQ, RTM, audit trails and validation closure.

Founder profile
Founder and Managing Director, PHARPRO
Pharmaceutical compliance consultant with more than seven years of hands-on validation experience, focused on computerized system validation, quality assurance, CQV, GMP training and responsible digital validation.
Professional focus
Mohammad leads PHARPRO’s client scoping and technical delivery across the pharmaceutical validation lifecycle. His work centres on converting regulatory expectations into controlled, risk-based systems: defining intended use, identifying critical functions, writing and executing proportionate qualification activities, maintaining requirements traceability and ensuring the final package can be understood by both the client’s quality unit and an inspector.
He works with pharmaceutical manufacturers, distributors and regulated technology teams across MENA through on-site, remote and hybrid engagements. Final quality decisions and approvals remain with the regulated company; PHARPRO’s role is to provide independent analysis, practical controls and defensible documentation.
Areas of expertise
GAMP 5 lifecycle strategy, 21 CFR Part 11, Annex 11, URS, risk assessment, IQ/OQ/PQ, RTM, audit trails and validation closure.
GMP gap assessments, SOP systems, CAPA, deviations, data-integrity remediation and evidence preparation for authority inspections.
Qualification planning and evidence for facilities, utilities, equipment, HVAC, warehouses, cold rooms and controlled environments.
Instructor-led training in English and Arabic using real documentation examples, exercises and decisions from regulated projects.
Responsible AI-assisted documentation, human review, role-based approval and traceability through PHARPRO DVS.
Regional project experience and regulatory alignment for Jordan, UAE, Saudi Arabia, Egypt and other MENA markets.
Selected guidance
These guides are educational and should be applied through the regulated company’s approved quality system and product-specific risk assessment.
Share the project, system or inspection priority. Mohammad normally responds within one business day.
Request a free assessment